CXCL10 and colorectal carcinoma: Consistent with our observation, CXCL10 was shown to direct the polarization of CD4+ T cells into potent effector IFN-γhiIL-4lo Th1 cells (15), and low transcript levels of CXCL10 in CRC patients are associated with poor prognosis (16).